Physician profile
Shauna E Berry
NPI 1548605967
$1,735.97
in general payments reported to CMS, 2019-2025
8 companies · $1,172 in 2025
The $1,172 reported for 2025 was more than what 80% of Neuro-Ophthalmology providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.51 · 2020: $151 · 2021: $135 · 2024: $250 · 2025: $1,172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,282 · Long Term Medical Supply Or Device Loan: $139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,282.37 |
| Long Term Medical Supply Or Device Loan | $139.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $935.11 | 2024-2025 | Tepezza |
| Horizon Therapeutics Plc | $274.36 | 2020-2021 | |
| Biotissue Holdings INC. | $172.13 | 2025 | |
| Baxter Healthcare | $139.20 | 2025 | Hillrom - Spot Vision Screener |
| Mallinckrodt Hospital Products INC. | $103.60 | 2021-2025 | Acthar |
| Catalyst Pharmaceuticals, INC. | $83.06 | 2025 | |
| Boston Scientific Corporation | $15.12 | 2019 | |
| Travere Therapeutics, INC. | $13.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shauna Berry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.